Proton therapy for prostate cancer is advantageous to IMRT according to new study

Proton therapy treatment for prostate cancer is associated with higher survival rates and decreased risk of complications compared to intensity-modulated radiation therapy according to a new study by researchers at the Northwestern Medicine Chicago Proton Centre The study is being presented at the 4th Annual Particle Therapy Co-Operative Group North-America Conference in Chicago.